Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Relmada Therapeutics, Inc.”

7 pharma patents match "Relmada Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Relmada Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Relmada Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11607407

    Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use

    Relmada Therapeutics, Inc. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted
  2. US 10624887

    Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol

    Relmada Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  3. US 9855226

    d-methadone for the treatment of psychiatric symptoms

    Relmada Therapeutics, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  4. US 9468611

    d-Methadone for the treatment of psychiatric symptoms

    Relmada Therapeutics, Inc. · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  5. US 9364430

    Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol

    Relmada Therapeutics, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  6. US 9125833

    Multimodal abuse resistant and extended release opioid formulations

    Relmada Therapeutics, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  7. US 8329744

    Methods of preventing the serotonin syndrome and compositions for use thereof

    Relmada Therapeutics, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted